stoxline Quote Chart Rank Option Currency Glossary
  
Nuwellis, Inc. (NUWE)
0.3143  -0.055 (-14.82%)    06-12 16:00
Open: 0.3041
High: 0.3507
Volume: 8,984,127
  
Pre. Close: 0.369
Low: 0.3041
Market Cap: 1(M)
Technical analysis
2025-06-12 4:50:19 PM
Short term     
Mid term     
Targets 6-month :  0.83 1-year :  1.2
Resists First :  0.71 Second :  1.02
Pivot price 0.66
Supports First :  0.21 Second :  0.17
MAs MA(5) :  0.31 MA(20) :  0.73
MA(100) :  1.02 MA(250) :  1.73
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  12.2 D(3) :  6.9
RSI RSI(14): 24.9
52-week High :  8.39 Low :  0.21
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ NUWE ] has closed above bottom band by 17.1%. Bollinger Bands are 267.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.35 - 0.35 0.35 - 0.35
Low: 0.3 - 0.3 0.3 - 0.3
Close: 0.31 - 0.31 0.31 - 0.32
Company Description

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Headline News

Tue, 10 Jun 2025
Nuwellis Secures $5M Through Public Offering: Complete Details on Stock and Warrant Terms Revealed - Stock Titan

Mon, 09 Jun 2025
Nuwellis (NUWE) Announces Stock Offering, Shares Plummet - GuruFocus

Mon, 09 Jun 2025
Worst performing stock today: Nuwellis (NASDAQ:NUWE) stock down over 34.19% - Markets.com

Mon, 09 Jun 2025
Nuwellis (NUWE) Details Public Offering with Multiple Warrants | NUWE Stock News - GuruFocus

Mon, 09 Jun 2025
Nuwellis Announces Pricing of $4.3 Million Underwritten Public O - GuruFocus

Mon, 09 Jun 2025
Nuwellis Launches Complex $4.3M Public Offering with Multi-Tier Warrant Structure - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 4 (M)
Shares Float 4 (M)
Held by Insiders 0 (%)
Held by Institutions 3.1 (%)
Shares Short 62 (K)
Shares Short P.Month 80 (K)
Stock Financials
EPS 15.01
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.81
Profit Margin -112.1 %
Operating Margin -160.8 %
Return on Assets (ttm) -83.7 %
Return on Equity (ttm) -440.8 %
Qtrly Rev. Growth 2.5 %
Gross Profit (p.s.) 1.3
Sales Per Share 2.01
EBITDA (p.s.) -2.03
Qtrly Earnings Growth 0 %
Operating Cash Flow -9 (M)
Levered Free Cash Flow -10 (M)
Stock Valuations
PE Ratio 0.02
PEG Ratio 0
Price to Book value 0.38
Price to Sales 0.15
Price to Cash Flow -0.15
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android